Skip to main content

The judge overseeing Purdue Pharma’s bankruptcy on Friday urged opponents of the OxyContin maker’s reorganization plan, which would resolve widespread opioid litigation, to settle quickly with the company’s Sackler family owners because it would save time and money on appeals later.

U.S. Bankruptcy Judge Robert Drain in White Plains, N.Y., made his remark during a hearing on Friday morning, five days before he is set to rule on the plan.

The deal, if approved, would clear a path to resolve thousands of opioid lawsuits and shield the Sackler family owners from future litigation. Opponents of the deal have said the releases are too broad.

“I think, having heard the lawyers from both sides – they are very talented lawyers, they know the risks they face – I would hope their clients would also be realistic about those risks,” Justice Drain said.

Purdue has said the deal, which directs funding toward opioid abatement programs, is worth more than US$10-billion. The Sacklers have agreed to contribute approximately US$4.5-billion.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Follow related authors and topics

Authors and topics you follow will be added to your personal news feed in Following.

Interact with The Globe